Adia Med swings to Q3 net loss of $53,015 as revenue rises 37% to $454,385
ADIA•Adia Med reported a third-quarter 2026 net loss of $53,015, compared with net income of $70,376 a year earlier, while revenue rose 37% to $454,385. Nine-month revenue climbed 95% to $1.02 million, and the company sold a 30% interest in Adia Labs for $1.5 million.
1. Quarterly results
Adia Med swung to a third-quarter 2026 net loss of $53,015 from net income of $70,376 a year earlier. Revenue rose 37% year over year to $454,385. For the nine months, revenue climbed 95% to $1.02 million, while the net loss widened 60% to $271,922, reflecting continued investment in growth.
2. Adia Labs stake sale
On September 30, Adia Med sold a 30% interest in Adia Labs to Live Oak Health for $1.5 million and retained majority ownership.




